These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11436964)

  • 41. No recurrence of a neuroleptic malignant syndrome under quetiapine.
    Brieger P; Reinelt Y
    Aust N Z J Psychiatry; 2003 Oct; 37(5):627. PubMed ID: 14511095
    [No Abstract]   [Full Text] [Related]  

  • 42. Quetiapine: novel uses in the treatment of depressive and anxiety disorders.
    Ravindran AV; Al-Subaie A; Abraham G
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1187-204. PubMed ID: 20795889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjunctive quetiapine targets self-harm behaviors in adolescent females with major depressive disorder.
    Good CR
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):235-6. PubMed ID: 16768629
    [No Abstract]   [Full Text] [Related]  

  • 44. [Buccolingual dyskinesia with justified hallucinations].
    Aragones JM; Blanch CE; Guillen-Font A; Escote-Llobet S
    Rev Neurol; 2014 Nov; 59(10):479. PubMed ID: 25354510
    [No Abstract]   [Full Text] [Related]  

  • 45. Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia: a randomized, open-label, parallel-group, flexible-dose study.
    Di Fiorino M; Montagnani G; Trespi G; Kasper S
    Int Clin Psychopharmacol; 2014 May; 29(3):166-76. PubMed ID: 24681810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treating psychosis in Parkinson's disease with atypical antipsychotics.
    Duggal HS; Singh I
    Eur Psychiatry; 2005 Jan; 20(1):83-4. PubMed ID: 15642454
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes.
    Kopala LC; Good KP; Milliken H; Buiteman C; Woodley H; Rui Q; Whitehorn D; Love L; Balshaw R; Kiss I; Honer WG
    Schizophr Res; 2006 Jan; 81(1):29-39. PubMed ID: 16263246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.
    Holzer L; Preuss U; Baumgartner L; Jaugey L; Urben S; Halfon O; Baumann P
    Pharmacopsychiatry; 2011 May; 44(3):87-95. PubMed ID: 21318938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.
    Fond G; MacGregor A; Ducasse D; Brittner M
    Psychiatry Res; 2014 May; 216(2):286-7. PubMed ID: 24582773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of quetiapine in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2002; 63 Suppl 13():27-31. PubMed ID: 12562144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The emergency treatment of depression complicated by psychosis or agitation.
    Glick RL; Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quetiapine induced restless legs syndrome: A series of four cases.
    Vohra A
    Asian J Psychiatr; 2015 Aug; 16():73-4. PubMed ID: 26096664
    [No Abstract]   [Full Text] [Related]  

  • 54. Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.
    Adetunji B; Basil B; Mathews M; Williams A; Osinowo T
    J Clin Psychiatry; 2006 Mar; 67(3):497; author reply 497-8. PubMed ID: 16649843
    [No Abstract]   [Full Text] [Related]  

  • 55. Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.
    Devarajan S; Ali J; Dursun SM
    Psychopharmacology (Berl); 2006 Apr; 185(3):402-3. PubMed ID: 16538471
    [No Abstract]   [Full Text] [Related]  

  • 56. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 57. Ventricular ectopics during crossover of atypical antipsychotics.
    O'Shea M; Sazhin V; Collins A
    Aust N Z J Psychiatry; 2003 Dec; 37(6):773-4. PubMed ID: 14636396
    [No Abstract]   [Full Text] [Related]  

  • 58. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Switching antipsychotics: an updated review with a focus on quetiapine.
    Weiden PJ
    J Psychopharmacol; 2006 Jan; 20(1):104-18. PubMed ID: 16204323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quetiapine blood level variability.
    Savasi I; Millson RC; Owen JA
    Can J Psychiatry; 2002 Feb; 47(1):94. PubMed ID: 11873715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.